Since joining Robins Kaplan, Holly Dolejsi has been heavily involved in some of the most notable cases handled by firm’s Mass Tort group. Most often, she represents individuals harmed by medical devices or pharmaceuticals. A key to her effective advocacy is that she never lets the size of the case keep her from remembering the individual. Always foremost in her mind, each and every client benefits from her compassion, dedication, and legal skills. She listens, she empathizes, and uses her considerable talents to bring relief.
Her peers recognize her outstanding skills as well, often referring clients to her and choosing her to serve in major roles in big cases involving serious issues. Most often, she represents individuals harmed by medical devices or pharmaceuticals. She is also handling cases on behalf of dozens of Native American tribes for damages caused by the opioid epidemic, as well as the State of Minnesota in its case against JUUL for damages caused by the youth vaping epidemic in Minnesota.
These matters are complex, often high-profile cases that tread new ground. They demand an intelligent, focused, organized attorney driven by the desire to learn and grow. Holly brings those talents to Robins every day, along with empathy for the individuals involved and a passion to bring them relief.
State of Minnesota v. Juul Labs, Inc. et al., Case No. 27-CV-19-19888: Represented the State of Minnesota in litigation against e-cigarette manufacturer JUUL and Altria for deceptively marketing tobacco products and targeting Minnesota’s youth. After a three-week trial, JUUL and Altria were ordered to pay a total of $60.5 million to the State of Minnesota over an eight-year period. This settlement is the largest per capita of all 48 states and territories that have settled with JUUL.
In Re: National Prescription Opiate Litigation, MDL No. 2804, Case No. 17-md-02804: Represented 28 Tribal Nations asserting that the manufacturers of prescription opioids grossly misrepresented the risks of long-term use of those drugs for persons with chronic pain, and distributors failed to properly monitor suspicious orders of those prescription drugs, all of which contributed to the current opioid epidemic. Robins Kaplan obtained a historic first in Tribal Government litigation, with a total of $1.5 billion in settlements obtained on behalf of the Tribal Nations.
In re Farxiga (Dapagliflozin) Products Liability Litigation, MDL No. 2776: Appointed Co-Lead Counsel of the Farxiga Multidistrict Litigation. Farxiga is diabetes drugs which Plaintiffs allege caused ketoacidosis. This woman-run MDL resolved in just under three years.
Benicar Multi-District Litigation, MDL No. 2606 (D.N.J.): Represented clients in, and served on the Bellwether Committee of, the Benicar (Olmesartan) Multi-District Litigation. The MDL reached a global $358 million settlement.
In Re: Invokana (Canagliflozin) Product Liability Litigation, MDL No. 2750: Served on the Plaintiffs’ Steering Committee of the Invokana Multi-District litigation.
Stryker Rejuvenate and ABG II Hip Step New Jersey Multi-County Litigation, MCL 296: Represented clients in the New Jersey Multi-County Stryker Rejuvenate and ABG II Modular Hip Stem litigation, including two Plaintiffs who resolved their cases through the NJ Court’s bellwether mediation program. Assisted in developing a global settlement program for both the multi-county litigation and the federal multi-district litigation, a program valued at over $1 billion.
- "Law360 2023 Product Liability Editorial Board," Law360 (August 7, 2023)
- "Will Bankruptcy Judge Bend On Halting Talc Cases Against J&J? Juul Settles AG Cases But SF Trial Looms," ALM Litigation: Editor's Picks (April 19, 2023)
- "2022 Attorneys of the Year: National Prescription Opiate Litigation," Minnesota Lawyer (February 16, 2023)
- "For some transgender people, a legal name change is a big step forward," MPR News (December 15, 2022)
- "Robins Kaplan on the Front Lines of $589M National Opioid Settlement on Behalf of Tribal Nations, Attorney at Law Magazine (March 2022)
- "Taking a Stand for Justice," profiled in Attorney at Law Magazine's 2020 Next Generation Attorney Series (May 2020)
If you are interested in having us represent you, you should call us so we can determine whether the matter is one for which we are willing or able to accept professional responsibility. We will not make this determination by e-mail communication. The telephone numbers and addresses for our offices are listed on this page. We reserve the right to decline any representation. We may be required to decline representation if it would create a conflict of interest with our other clients.
By accepting these terms, you are confirming that you have read and understood this important notice.